Writing A History And Physical And Documentation

1-2 Writing A History And Physical And Documentation

With Dr. Thomas O'Connor  Founder / CEO Testosteronology Society™ 

1) The Purpose Of Structured History In Androgen Medicine

Structured history is the fastest way to prevent misclassification because androgen complaints overlap with many other drivers. A casual conversation history tends to follow the patient’s narrative, and the patient’s narrative is often shaped by online language, target numbers, and optimization expectations. The Testosteronology® framework treats history as evidence gathering that must be repeatable, because repeatable history produces repeatable decisions. The goal is not length, it is coverage of the variables that most commonly distort symptoms and labs. When history is structured, the clinician becomes less reactive, the monitoring plan becomes clearer, and documentation becomes easier to defend.

Structured history also protects patients from premature lifelong labels. Many patients have reversible suppression patterns driven by sleep disruption, caloric deficit, stress physiology, medication effects, or metabolic drift. If the clinician skips those drivers, the clinician may prescribe to a symptom story rather than to a defensible indication. ABCDS™ fits naturally because glycemic trajectory, blood pressure load, lipid context, hematocrit behavior, sleep stability, and symptom function provide a stable context for interpreting what the patient is experiencing. This section sets the idea that history is not intake, it is clinical reasoning in progress.

2) Chief Complaint Translation Into Testable Clinical Hypotheses

Chief complaints are often conclusions rather than questions. “My testosterone is low” is a belief about causality, not a symptom description. “I want TRT” is a request for an intervention, not a diagnosis. Translating the complaint means turning it into something testable: what function is impaired, what changed, and what drivers could plausibly explain the change. When the hypothesis is clear, labs are ordered with purpose rather than ordered as reassurance. This is one of the most important habits in the Testosteronology® framework because it keeps clinicians from chasing panels without a decision question.

A practical way to do this is to write a one-sentence hypothesis before ordering labs, then ask what evidence would support or refute it. When the patient wants certainty, the clinician can offer structure instead: a timeline, a plan, and a reassessment checkpoint. This prevents negotiation-driven medicine and keeps the encounter medical. It also improves documentation because the note can state the working hypothesis and the planned tests that answer it.

3) Symptom Timelines And What Timing Reveals

Timing is a diagnostic tool because timing reveals whether the complaint is curve-related, driver-related, or unrelated to hormones. Patients often describe “wear-off” patterns that are actually missed doses, poor technique, or peak-trough volatility rather than true under-replacement. Other patients describe seasonal or stress-linked fatigue that is unrelated to hormones and tied to sleep disruption or life context. If timing is missing, clinicians treat symptoms as static and then apply static solutions that fail in real life. A structured timeline also makes follow-up visits more interpretable because you can compare today’s pattern to last visit’s pattern.

Timeline questions that consistently change decisions:

• When did the symptom start, and what changed in life, sleep, training, or medications then
• Is the symptom steady or does it fluctuate across days and weeks
• Does it map to dosing days, missed doses, or application routine
• Does it worsen with poor sleep weeks, travel, alcohol, or stimulant changes
• Did it begin after dieting, overtraining, injury, or illness episodes
• What does a “good week” look like compared with a “bad week”

ABCDS™ supports timeline work because domain drift often follows the same timeline, especially sleep stability and blood pressure patterns. This is how clinicians avoid treating a bad week as a diagnosis.

4) Exposure History: Testosterone, AAS, SARMs, And Supplements

Exposure history is clinical data because prior exposure changes physiology, recovery timelines, and symptom narratives. Prior TRT and AAS exposure can create prolonged suppression patterns and unstable gonadotropin profiles. SARMs and underground products add uncertainty because dosing is unknown and contaminants are common. Supplements matter because stimulant-heavy stacks can fragment sleep, increase anxiety, and create fatigue narratives that look endocrine. Exposure history must be taken neutrally because shame reduces disclosure, and disclosure is needed for safe decisions. This is a core Testosteronology® habit because exposure explains many cases that otherwise look mysterious.

High-yield exposure questions that should be routine:

• Prior TRT, AAS, or cycle history, including start-stop patterns and cessation timing
• Current dosing schedule, missed doses, and self-adjustment behavior
• Use of aromatase inhibitors, SERMs, peptides, stimulants, or sleep agents
• Supplement use, including pre-workouts, fat burners, and libido products
• Source of products and whether dosing is consistent or improvised
• Fertility goals and any prior fertility suppression history

A clinician who documents exposure clearly prevents misclassification and prevents future clinicians from repeating the same trial-and-error cycle.

5) Medication Review And Endocrine Suppression Risk

Medication effects are one of the most common confounders in androgen care, and they often explain symptom-lab mismatch better than testosterone does. Psychotropics can alter libido, orgasm, sleep architecture, and motivation. Opioids can suppress axis signaling and worsen mood and fatigue independently. Glucocorticoids can suppress signaling and shift metabolic physiology. Stimulants can fragment sleep, raise anxiety, and worsen blood pressure drift, creating fatigue that patients label as low testosterone. The clinician should treat medication review as endocrine reasoning, not as a clerical list.

Medication review should be timed. When did a medication start, stop, or change, and what changed after that change. If libido decline began after SSRI initiation, that is a different decision pathway than a libido decline that began after sleep apnea symptoms started. ABCDS™ ties medication review into monitoring because many medications change blood pressure patterns, glycemic trajectory, lipid context, and sleep stability. Documenting medication drivers clearly makes deferral decisions defensible and reduces escalation pressure that is really medication-driven.

6) Sleep History And Screening For Obstructive Sleep Apnea

Sleep is a primary driver of symptoms and a primary driver of safety in androgen care. Sleep apnea can mimic androgen deficiency symptoms and can blunt response even when levels rise. Sleep apnea also increases hematocrit risk and can worsen blood pressure drift, which becomes critical once therapy begins. Many patients describe fatigue and low drive that are sleep stories, not testosterone stories, and structured sleep history prevents mislabeling. In the Testosteronology® framework, sleep screening is part of classification discipline and part of monitoring discipline.

Practical sleep screening cues clinicians should capture:

• Snoring, witnessed apneas, gasping, or choking during sleep
• Morning headaches, dry mouth, unrefreshing sleep, and daytime sleepiness
• Nocturia patterns that may reflect disrupted sleep continuity
• Alcohol, sedatives, and stimulant use that fragment sleep or worsen airway stability
• Weight trajectory and risk cues that increase apnea probability
• Prior sleep study history and whether CPAP was prescribed and used

ABCDS™ connects sleep to hematocrit and blood pressure trends, which makes sleep counseling more persuasive and monitoring more defensible.

7) Metabolic And Cardiovascular Risk Review For Treatment Planning

Metabolic and cardiovascular risk review is inseparable from androgen care in the Testosteronology® framework because prevention domains shape both symptoms and safety. Insulin resistance drives fatigue and mood symptoms and also alters SHBG, which confounds lab interpretation. Hypertension risk matters because sleep disruption, sodium load, alcohol use, and volatility can worsen blood pressure during therapy. Lipid trajectory matters because risk accumulates silently, especially when patients feel better and become less cautious. A clinician who ignores these domains creates short-term symptom relief at the cost of long-term risk drift.

ABCDS™ provides a structured way to capture this efficiently without turning the visit into a cardiology consult. The clinician should document baseline status, trend direction when known, and what follow-up cadence will be used. When metabolic drift is worsening, escalating testosterone often masks the driver rather than fixing it. This section trains clinicians to treat prevention as part of accountable androgen care rather than as separate primary care work.

8) Fertility Goals And Reproductive History

Fertility counseling is required because exogenous testosterone suppresses spermatogenesis reliably and regret is common when this is skipped. Many patients say fertility does not matter until life plans change, and those changes can occur quickly. Reproductive history includes current goals, near-term timelines, prior infertility, and prior prolonged suppression after exposure. Fertility goals can change the plan immediately, especially for younger men or for those with mixed motives. In the Testosteronology® framework, fertility discussion is part of defensible initiation and part of ethical care.

Documentation should record that fertility impact was discussed and what the patient understood. If the patient declines fertility preservation planning, document the declination and how it narrows safe options. ABCDS™ remains relevant because metabolic and sleep stability influence fertility and influence recovery potential. This section helps clinicians prevent future regret and prevent future disputes.

9) Focused Physical Examination For Androgen Care

A focused exam adds probability-weighting and improves defensibility without requiring a long checklist. Blood pressure measurement is basic but essential because it anchors the monitoring plan. Body composition cues and signs of sleep-disordered breathing risk can shift interpretation toward driver-focused care rather than hormone escalation. Testicular findings, secondary sexual characteristics, and general endocrine clues can support or challenge the working classification. In telehealth contexts, documenting exam limitations is part of defensible care because the record must be honest about what was assessed.

The exam should be targeted to the hypothesis and to the patient’s risk profile. A clinician who performs and documents a focused exam reduces missed red flags and improves the quality of follow-up decisions. ABCDS™ provides the map for what exam elements matter most in monitoring, especially blood pressure and weight trajectory.

10) Red Flags And When To Expand Evaluation Or Refer

Red flags are where disciplined clinicians change posture from routine evaluation to escalation and referral. Severe headaches with visual symptoms, galactorrhea with libido collapse, unexplained rapid changes, or multiple pituitary axis symptoms warrant deeper evaluation. Persistent extreme abnormalities across repeat stable testing should shift probability toward organic pathology and prompt referral. Severe psychiatric instability, severe sleep apnea suspicion, or uncontrolled cardiometabolic risk should change initiation posture because safety and adherence are compromised. A structured red-flag approach prevents both delayed diagnosis and reckless prescribing.

Referral notes should be focused and factual. State the clinical question and the key evidence, not a vague request to “evaluate hormones.” Documentation should capture why the referral was needed and what is being ruled out. This section reinforces that escalation is part of medicine-first care and improves defensibility.

11) Documentation Structure That Preserves Defensibility And Continuity

Documentation is clinical work in Testosteronology®, not administrative work, because the record is what preserves reasoning under scrutiny. A defensible note shows hypothesis, differential considered, timing context, exposure history, and risk domain review. It also shows what was offered, what was declined, and what the next decision checkpoint will evaluate. Without that structure, future clinicians repeat trial-and-error and patients restart negotiations. Notes should be readable and should tell the story quickly.

A practical documentation structure aligns to the clinician’s reasoning flow and uses consistent headings. ABCDS™ provides a stable way to document baseline and trend domains without writing essays. Document timing assumptions for labs and dosing because timing determines meaning. Document boundaries calmly when patients request optimization or supraphysiologic targets. This section teaches clinicians to write notes that other clinicians can follow quickly and that hold up under audit.

12) Follow-Up Documentation: Monitoring, Adjustments, And Stability Over Time

Follow-up notes are where many clinics drift into vague language like “doing well,” then lose defensibility when drift appears. Follow-up documentation should state what changed, what remained stable, and why the plan was continued or adjusted. Adjustments should be documented as hypotheses with reassessment windows, not as reactive responses to one bad week. Missed monitoring should be documented as a safety issue with a plan to restore data and a pause when needed. ABCDS™ domain trends should be recorded as stable, drifting, or unknown due to missing data, because that makes the record interpretable over time.

This section reinforces that follow-up is long-term care, not isolated visits. When follow-up documentation is structured, clinicians make fewer reactive changes, patients receive consistent messaging, and adverse drift is detected earlier. That is how volume can increase without quality falling. The goal is continuity that survives time, clinician changes, and patient movement between settings.

13) Course Summary

This course taught structured history, focused exam, and documentation as clinical safety tools in androgen care. Chief complaints were translated into testable hypotheses so labs support reasoning rather than replace it. Symptom timelines were emphasized because timing reveals whether complaints are kinetics-related, driver-related, or unrelated to hormones. Exposure history was treated as clinical data because TRT, AAS, SARMs, and supplements change physiology and risk tolerance. Medication review was emphasized because polypharmacy and endocrine suppression risk commonly masquerade as androgen deficiency. Sleep screening was treated as essential because apnea both mimics symptoms and amplifies hematologic and blood pressure risk. Metabolic and cardiovascular review was integrated as part of treatment planning consistent with the Testosteronology® framework. Fertility goals were treated as required counseling because exogenous testosterone suppresses spermatogenesis predictably. Red flags and referral triggers were included to prevent missed pathology and improve defensibility. ABCDS™ was used to structure baseline capture and follow-up stability trends. The outcome is better diagnostic clarity, safer follow-up decisions, and documentation that preserves continuity over time.

Recommended Grand Rounds Case Reviews

Grand Rounds 02-20-2025

A clinical discussion reviewing complex TRT case management, cardiovascular and hematologic risk considerations, therapeutic decision-making, and practical approaches to evaluating and treating low testosterone in real-world patients.  ⮕

Grand Rounds 10-23-2025

This meeting features a collaborative case-based discussion among Testosteronology Society™ clinicians centered on a complex borderline-polycythemic patient considering TRT, exploring diagnostic reasoning, risk assessment, and practical management strategies.  ⮕

Grand Rounds 1-22-2026

A discussion on age- and symptom-informed testosterone evaluation, documentation and coding practices to reduce regulatory risk, obesity-related secondary hypogonadism considerations, proposed research priorities, and practical access barriers involving retail pharmacies, compounding, and peptide sourcing.  ⮕